Robotic Inflammatory Bowel Disease Development, Learning and Efficacy Study
RIDDLE
1 other identifier
observational
100
1 country
6
Brief Summary
To determine if robotic surgery can be performed for inflammatory bowel disease (IBD) patients, to ascertain the optimal robotic set up for multi-quadrant IBD operations and evaluate clinical outcomes in robotic compared to laparoscopic surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2024
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 12, 2024
CompletedFirst Submitted
Initial submission to the registry
August 23, 2024
CompletedFirst Posted
Study publicly available on registry
August 30, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
CompletedDecember 10, 2025
March 1, 2025
1.8 years
August 23, 2024
December 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
To see if robotic surgery is technically feasible for patients with inflammatory bowel disease measured during intra-operative procedure that includes: estimated blood loss in mL.
12 months
Port placement using position of ports on the abdomen marked in a diagram during surgical procedure.
12 months
Docking of robotic arm in robotic surgery using number of times the docking was done with start and end docking time in HH:MM.
12 months
Operative time using time of surgery performed in HH:MM.
12 months
Eligibility Criteria
Patients undergoing surgery for inflammatory bowel disease
You may qualify if:
- Aged 18 years or over
- Undergoing IBD surgery using MIS (minimally invasive surgery) techniques
- Histological/radiological evidence of inflammatory bowel disease
You may not qualify if:
- Planned open surgical approach
- Lacks capacity to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (6)
University Hospitals Coventry & Warwickshire (UHCW) NHS Trust
Coventry, West Midlands, CV2 2DX, United Kingdom
Newcastle Hospitals NHS Foundation Trust
Newcastle upon Tyne, West Midlands, NE7 7DN, United Kingdom
Oxford University Hospitals NHS Foundation Trust
Oxford, West Midlands, OX3 9DU, United Kingdom
London North West University Healthcare NHS Trust
Harrow, HA1 3UJ, United Kingdom
Guy's and St Thomas NHS Foundation Trust
London, SE1 7EH, United Kingdom
Chelsea and Westminster Hospital NHS Foundation
London, SW10 9NH, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 23, 2024
First Posted
August 30, 2024
Study Start
July 12, 2024
Primary Completion
May 1, 2026
Study Completion
June 1, 2026
Last Updated
December 10, 2025
Record last verified: 2025-03